BRAF and acral lentiginous melanoma: Because the staining of VE1 in acral melanoma varied in both intensity and proportion, we regarded tissues as mutation-positive when at least 5% of melanoma cells expressed a positive staining of 1–3+, in accordance with the instructions of the Cobas BRAF V600E Mutation Test, which indicated a cutoff value of >5% of tumor DNA.